June 20th 2022
Medical experts detail the current and evolving roles of BTK inhibitors in treatment of patients with relapsed/refractory mantle cell lymphoma.
February 24th 2022
Experts in hematology/oncology share key insight on the treatment of CLL, including the use of BTK inhibitors and the critical role of pharmacists in disease management.
December 21st 2021
Considerations regarding updates to chronic lymphocytic leukemia treatment algorithms based on novel and emerging therapies presented at the ASH 2021 annual meeting.
December 17th 2021
Pharmacist and provider perspective on BTK inhibitors for Waldenstrom macroglobulinemia.
November 22nd 2021
Shared insight on unmet needs and recent innovations in the management of marginal zone lymphoma in the relapsed/refractory setting.
November 17th 2021
Joanna Lewis, PharmD, MBA, discusses practical considerations when selecting over-the-counter medications to treat common conditions pharmacists are often asked about and highlights some recommended medications from the Pharmacy Times’ OTC Guide
September 30th 2021
Bhavesh Shah, RPh, BCOP; and Thomasina Morris, RPh, MHA, BCOP, discuss the importance of utilizing PARP inhibitors as second-line maintenance therapy in ovarian cancer and share valuable clinical insights.